OnDemand WTP Pricing Research

Tag: Pricing Science

The Price of Price Controls: Innovation Likely to Suffer in Drug Pricing Debate | IPWatchDog

The Price of Price Controls: Innovation Likely to Suffer in Drug Pricing Debate | IPWatchDog

The Cost of Cheap The reason drugs are cheaper in other countries is because those other countries have price controls. If pharmaceutical companies want to sell into those countries, they have to charge those low prices. And if the required low price is set above the marginal cost to produce the drug, then the pharmaceutical […]

A new study sparks a war of words over pharma’s commitment to research | STAT

A new study sparks a war of words over pharma’s commitment to research | STAT

WASHINGTON — A coalition of the drug industry’s fiercest foes is accusing the world’s top drug makers of hiding behind research and development “as an excuse for price-gouging American patients.” And they’re pointing to a new study that finds drug makers spent about 22% of their revenues on research and development in 2017 to prove […]

Drug court to try firms refusing to cut prices | The Express Tribune

Drug court to try firms refusing to cut prices | The Express Tribune

ISLAMABAD: The government is expected to take up the issue of hike in drug prices at its next cabinet meeting while it intends to move the drug court against all those pharmaceutical companies who refuse to lower prices of their medicines in line with the recent policy decision of the government. This was disclosed by the […]

Pharma stocks crash after US lawsuit over price manipulations | The Economic Times

Pharma stocks crash after US lawsuit over price manipulations | The Economic Times

The office of the attorney general of Connecticut unsealed documents, that ET has a copy of, which reveals initials and titles of individuals implicated in the conspiracy, industry “code words” and previously undisclosed emails from drug companies “brazenly discussing strategy to violate federal and state antitrust laws”. The Indian generic makers named in the lawsuit […]

Beshear Files Claim Against Drug Manufacturers for alleged Price Gouging | SurfKY News

Beshear Files Claim Against Drug Manufacturers for alleged Price Gouging | SurfKY News

FRANKFORT, Ky. (5/13/19) — Attorney General Andy Beshear filed two lawsuits seeking to recover ill-gotten gains from 23 drug manufacturers that skyrocketed the prices of more than 100 prescription drugs including those used to treat diabetes, epilepsy and cancer. In Franklin Circuit Court, Beshear filed suit against three of the largest insulin manufacturers, Eli Lilly, […]

Nevada joins other states in drug price-fixing lawsuit | Las Vegas Review-Journal

Nevada joins other states in drug price-fixing lawsuit | Las Vegas Review-Journal

Nevada Attorney General Aaron Ford has signed on to a lawsuit filed by 42 states and Puerto Rico against a long list of pharmaceutical companies, alleging price fixing and market manipulation that artificially increased costs for dozens of common generic drugs nationwide. The lengthy complaint names drugmakers including Teva Pharmaceuticals USA Inc., Pfizer Inc., Breckenridge […]

Trump finalizes rule to require drug prices in TV ads | POLITICO

Trump finalizes rule to require drug prices in TV ads | POLITICO

The Trump administration finalized a rule Wednesday that requires drugmakers to disclose prices in television ads, despite skepticism the move will lower the high cost of drugs and concerns that sticker shock will frighten patients into going off their medications. Under the rule, which takes effect in 60 days, manufacturers must list a product’s monthly […]

GOP senators warn drug price controls could come | Modern Healthcare

GOP senators warn drug price controls could come | Modern Healthcare

Two Republican senators on Tuesday issued sharp warnings to the pharmaceutical industry about price controls. The GOP-led Senate Judiciary Committee hearing on Tuesday showed that the Trump administration’s idea of an international reference model, aimed at just a subset of Medicare drugs, has transformed at least some Republican thinking on the drug-pricing policy debate. The […]

First, a pricing scandal for Catalyst’s Firdapse. Next, off-label competition? | FiercePharma

First, a pricing scandal for Catalyst’s Firdapse. Next, off-label competition? | FiercePharma

For decades, Jacobus Pharmaceuticals gave away the unapproved drug amifampridine to patients with a rare neuromuscular disorder called LEMS. Then, Catalyst Pharma licensed certain rights to the drug, scored an FDA nod, and priced the med at $375,000 a year. An outcry ensued. But now, the FDA may have given patients a workaround. Jacobus won approval Monday […]

Medicare could save $73B by matching drug prices of other countries, study says | Becker’s Hospital Review

Medicare could save $73B by matching drug prices of other countries, study says | Becker’s Hospital Review

By using external reference pricing to match U.S. drug prices to those in Japan, the U.K. or Canada,  Medicare could have saved nearly $73 billion in 2018, according to a new study published in Health Affairs. Five things to know: 1. For the study, researchers analyzed 79 medicines that Medicare Part D spent the most on […]